Vitamin D modulation of the activity of estrogenic compounds in bone cells in vitro and in vivo

Critical Reviews in Eukaryotic Gene Expression

Volumn 17, Issue 2, 2007, Pages 115-147

  Somjen, Dalia ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Bone; Cartilage; Cell proliferation; Creatine kinase; Estrogen; Vitamin D

Indexed keywords

ANDROSTANOLONE; CREATINE KINASE; ESTRADIOL; PARATHYROID HORMONE; RALOXIFENE; VITAMIN D DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; BONE CELL; BONE INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENERGY METABOLISM; ENZYME ACTIVITY; ESTROGEN ACTIVITY; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOBLAST; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; UPREGULATION;

RATTUS; TULIP BREAKING VIRUS;

EID: 34249804503     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/critreveukargeneexpr.v17.i2.30     Document Type: Article

References (70)

1. Shen Q, Christakos S. The vitamin D receptor, RUNX2 and the notch-signaling pathway cooperate in the transcriptional regulation of osteopontin. J Biol Chem. 2005;280:40589-98.
2. Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, Denhart D. Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci U S A. 1990;87:9995-9.
3. Vertino AM, Bula CM, Chen JR, Almeida M, Han L, Bellido T, Kousteni S, Norman AW, Manolagas SC. Nongenotropic, anti-apoptotic signaling of 1alpha, 25(OH) 2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J Biol Chem. 2005;280:14130-7.
4. Eriksen EF, Glerup H. Vitamin D deficiency and aging: implications for general health and osteoporosis. Biogerontology. 2002;3:73-7.
5. Gallagher JC. Drug therapy of osteoporosis: calcium, estrogen and vitamin D. In: Riggs BL, Melton LJ III, editors. Osteoporosis: etiology, diagnosis and management. Vol. 1. New York: Raven Press; 1988. p. 389-401.
6. Tanaka H, Seino Y. Vitamin D metabolites and bone. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. San Diego: Academic Press; 1997. p. 305-11.
7. Holick MF. The vitamin D epidemic and its health consequences. J Nutr. 2005;135:2739S-48S.
8. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80 Suppl:1678S-88S.
9. 3. J Bone Miner Res. 1991;6:1021-7.
10. 3. Trends Endocrinol Metab. 1998;9:419-27.
11. 3 (JKF) up regulates the induction of creatine kinase B by 17β estradiol in osteoblast-like ROS 17/2.8 cells and in rat diaphysis. J Steroid Biochem Mol Biol. 2001;77:205-12.
12. Somjen D, Katzburg S, Sharon O, Kaye AM, Gayer B, Kohen F, Hendel D, Posner GH. Modulation of response to estrogens in human female bone cells by a non-calcemic vitamin D analog: changes in nuclear and membranal binding. J Steroid Biochem Mol Biol. 2004;89-90:393-5.
13. Somjen D, Waisman A, Weisman Y, Kaye AM. "Non-hypercalcemic" analogs of 1α, 25 dihydroxy vitamin D augment the induction of creatine kinase B by estrogen and selective estrogen receptor modulators (SERMS) in osteoblast-like cells and rat skeletal organs. J Steroid Biochem Mol Biol. 2000;72:79-88.
14. Fournier B, Haring S, Kaye AM, Somjen D. Stimulation of creatine kinase specific activity in human osteoblast and endometrial cells by estrogens and antiestrogens and its modulation by calciotropic hormones. J Endocrinol. 1996;150:275-85.
15. 2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry. Steroids. 2004;69:757-62.
16. Posner GH, Lee SH, Kim HJ, Peleg S, Dolan P, Kensler TW. Novel A-ring analogs of the hormone 1alpha, 25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation. Bioorg Med Chem. 2005;13: 2959-66.
17. Somjen D, Waisman A, Weisman Y, Kaye AM. Non hypercalcemic analogs of vitamin D stimulate creatine kinase activity in osteoblast-like ROS 17/2.8 cells and up-regulate their responsiveness to estrogens. Steroids. 1988;63:340-3.
18. Kaye AM, Kim TY, Kohen F, Somjen D. Anabolic effects of estrogen and parathyroid hormone on skeletal tissues: the use of creatine kinase B activity as a response marker. Arch Gerontol Geriatr. 1997;24:197-209.
19. Somjen D, Posner GH, Weisman Y, Kaye AM. Lesscalcemic vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in the rat skeletal tissues. J Endocr Invest. 2007;30:91-6.
20. 3 analogs JKF or QW increase both the morphological and biochemical responses to gonadal steroids in rat tibiae. J Cell Biochem. 2006;100:1406-14.
21. Somjen D, Harell A, Weisman Y. Reciprocal modulation by sex steroids and calcitropic hormones of skeletal cell proliferation. J Steroid Biochem Mol Biol. 1990;37:491-9.
22. Somjen D, Kaye AM, Harell A, Weisman Y. Modulation by vitamin D status of the responsiveness of rat bone to gonadal steroids. Endocrinology. 1989;125:1870-6.
23. Somjen D, Kohen F, Gayer B, Sharon O, Limor R, Kulik T, Knoll E, Stern N. Role of putative membrane receptors in estradiol's effects on human vascular cell growth. Am J Hypertens. 2004;7:462-9.
24. Reiss N, Kaye AM. Identification of the major component of the estrogen induced protein of rat uterus as the BB isozyme of creatine kinase. J Biol Chem. 1981;256:1907-12.
25. Malnick SDH, Shaer A, Soreq H, Kaye AM. Estrogen induced creatine kinase in the reproductive system of the immature female rat. Endocrinology 1983;19:1907-9.
26. Kaye AM, Weisman Y, Harell A, Somjen D. Hormonal stimulation of bone cell proliferation. J Steroid Biochem Mol Biol. 1990;37:431-5.
27. 2 vitamin D increases synergistically responsiveness to sex steroids in skeletal-derived cells. J Steroid Biochem Mol Biol. 1995;55:211-7.
28. Kensler TW, Dolan PM, Gange SJ, Lee L-K, Wang Q, Posner G. Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis. Carcinogenesis. 2000;21:1341-5.
29. Feldman D, Malloy PJ, Goldschmidt D, Gross C. Vitamin D: biology, action and clinical implications. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. Vol. 1. San Diego: Academic Press; 2001. p. 257-30.
30. 3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol. 2001;10:2465-73.
31. 3-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86:888-94.
32. 3 in vitro synthesis by human decidua and placenta. Nature. 1979;281:317-9.
33. Pillai S, Bikle DD, Elias PM. 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem. 1988;263:5390-5.
34. 3 by normal human macrophages. Biochem Biophys Res Commun. 1985;127:596-603.
35. Holick MF. Prostatic 25-hydroxy vitamin D-1-alphahydroxylase and its implication in prostate cancer. J Cell Biochem. 2003;88:315-22.
36. Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet. 2001;357:1673-4.
37. 3-1α hydroxylase is expressed in human vascular smooth muscle cells and is up regulated by parathyroid hormone and estrogenic compounds. Circulation. 2005;111:1666-71.
38. Harrison JR, Petersen DN, Lichtler AC, Mador AT, Rowe DW, Kream BE. 1,25-Dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. Endocrinology. 1989;125:327-33.
39. Price PA. Role of vitamin-K-dependent proteins in bone metabolism. Annu Rev Nutr. 1988;8:565-83.
40. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, Stewart PM, Hewison M. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol. 2002;13:621-9.
41. 3 on the expression of DNA replication genes. J Bone Miner Res. 2004;19:133-46.
42. Turner RT, Puzas JE, Forte MD, Lester GE, Gray TK, Howard GA, Baylink DJ. In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc Natl Acad Sci U S A. 1980;77:5720-4.
43. 3. J Biol Chem. 1981;256:7738-40.
44. Hossain M. Vitamin-D intoxication during treatment of hypoparathyrodism. Lancet. 1970;1:1149-51.
45. Berger E, Frisch B, Lifschitz-Mercer B, Weisman Y, Somjen D. Sequential treatment with vitamin D analogs and gonadal steroids augments anabolic changes in rat bone and cartilage [abstract]. 11th International Workshop on Calcified Tissues; 1999 Feb 7-11; Eilat, Israel. p. 106.
46. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
47. Katzburg S, Hendel D, Waisman A, Posner GH, Kaye AM, Somjen D. Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts. J Steroid Biochem Mol Biol. 2004;88:213-9.
48. Guzey M, Luo J, Getzenberg RH. Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells J Cell Biochem. 2004;93:271-85.
49. 3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res. 2000;6:3371-9.
50. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD, Martin MB. Regulation of estrogen receptor-alpha gene expression by 1, 25-dihydroxyvitamin D in MCF-7 cells. J Cell Biochem. 1999;75:640-51.
51. Morris HA. Vitamin D: a hormone for all seasons - how much is enough? Understanding the new pressures. Clin Biochem Rev. 2005;26:21-32.
52. 3 and two synthetic analogues in three in vivo models of prostate cancer. Br J Urol Int. 2002;90:607-16.
53. Dixon KM, Deo SS, Wong G, Slater M, Norman AW, Bishop JE, Posner GH, Ishizuka S, Halliday GM, Reeve VE, Mason RS. Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol. 2005;97:137-43. Epub 2005 Jul 20.
54. Uchiyama Y, Miyama K, Kataginri T, Yamaguchi A, Takamori H, Nakashima K, Sato T, Suda T. Adipose conversion is accelerated in bone marrow cells of congenitally osteoporotic SAMP6 mice. J Bone Miner Res. 1994;9 Suppl 1:B365.
55. Gimble JM, Robinson CE, Wu X, Kelly KA. The function of adipocytes in the bone marrow stroma: an update. Bone. 1996;19:421-8.
56. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I. Adipogenesis and aging: does aging make fat go mad? Exp Gerontol. 2002;37:757-67.
57. Aubin JE, Turksen K, Heersch JNM. Osteoblastic cell lineage. In: Noda M, editor. Cellular and molecular biology of bone. New York: Academic Press; 1993. p. 1-45.
58. Minaire P, Edouard C, Arlot M, Meunier PJ. Marrow changes in paraplegic patients. Calcif Tissue Int. 1984;36:338-40.
59. Martin RB, Zissimos SL. Relationships between marrow fat and bone turnover in ovariectomized and intact rats. Bone. 1991;12:123-31.
60. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev. 1992;13:719-64.
61. Hewison M, O'Riordan JLH. Immunomodulatory and cell differentiation effects of vitamin D. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. San Diego: Academic Press; 1997. p. 447-62.
62. Williams PJ, Brain DC, Peddie NJ, Taylor TG. Effects of estrone and estradiol-17β on 25-hydroxy cholecalcyferol hydroxylase activities in female Japanese quail. Gen Comp Endocrinol. 1988;7:97-104.
63. 3-1 alpha-hydroxylase by estrogen. Arch Biochem Biophys. 1977;179:211-7.
64. Cheema C, Grant BF, Marcus R. Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women. J Clin Invest. 1989;83:537-42.
65. Aarskog D, Aksnes L, Markestad T, Rodland O. Effect of estrogen on vitamin D metabolism in tall girls. J Clin Endocrinol Metab. 1983;57:1155-8.
66. Kallay E, Adlercreutz H, Farhan H, Lechner D, Bajna E, Gerdenitsch W, Campbell M, Cross HS. Phytoestrogens regulate vitamin D metabolism in the mouse colon: relevance for colon tumour prevention and therapy. J Nutr. 2002;132:3490S-3S.
67. Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ. Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr. 2004;134:1207S-12S.
68. Suda T, Ueno Y, Fujii K, Shinki T. Vitamin D and bone. J Cell Biochem. 2003;88:259-66.
69. Lian JB, Stein GS, Stein JL, van Wijnen AJ. Regulated expression of the bone-specific osteocalcin gene by vitamins and hormones. Vitam Horm. 1999;55:443-509.
70. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Lentile R, Squadrito F. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo- controlled study. J Bone Miner Res. 2002;17:1904-12.